The groundbreaking success of Viagra, developed by copyright, undeniably revolutionized the management of erectile dysfunctionality, and ignited a massive surge in the healthcare sector. However, now, investing in firms reliant on aging blockbuster drugs like Viagra presents a complex landscape.